domenica, 3 maggio 2026

Notizie AIOM – anno XV

17 Novembre 2017

FDA expands approval of Sunitinib to reduce the risk of kidney cancer returning

November 16, 2017 - The U.S. Food and Drug Administration today approved Sunitinib malate for the adjuvant treatment of adult patients who are at a high risk of kidney cancer (renal cell carcinoma) returning after a kidney has been removed (nephrectomy). Adjuvant treatment ...
Leggi tutto

17 Novembre 2017

Risk of Cardiovascular Ischemic Events After Surgical Castration and Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer: A Nationwide Cohort Study

Our aim was to determine whether cardiovascular (CV) risk in patients with prostate cancer (PCa) differs between those who receive androgen-deprivation therapy by surgical castration and those who receive gonadotropin-releasing hormone agonist (GnRHa) therapy. By using the ...
Leggi tutto

17 Novembre 2017

Observed benefit and safety of aflibercept in elderly patients with metastatic colorectal cancer: An age-based analysis from the randomized placebo-controlled phase III VELOUR trial

Aflibercept (ziv-aflibercept) significantly improves progression-free (PFS) and overall survival (OS) when added to 5-fluorouracil, leucovorin and irinotecan (FOLFIRI), compared with FOLFIRI alone, in patients with metastatic colorectal cancer previously treated with oxaliplatin-based ...
Leggi tutto

17 Novembre 2017

FDA Grants BCMA CAR T-Cell Therapy Breakthrough Designation in Myeloma

November 16, 2017 - The FDA has granted bb2121 a breakthrough therapy designation for previously treated patients with relapsed/refractory multiple myeloma, according to Celgene Corporation and bluebird bio, the companies developing the anti–B-cell maturation antigen ...
Leggi tutto

17 Novembre 2017

Brentuximab Vedotin Nears European Approval for CTCL

November 14, 2017 - The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of brentuximab vedotin in adults with CD30-positive cutaneous T-cell lymphoma (CTCL) after at least 1 prior systemic therapy, Takeda Pharmaceuticals, ...
Leggi tutto

17 Novembre 2017

ESMO Publishes Precision Medicine Glossary

November 16, 2017 - The European Society for Medical Oncology (ESMO) has published its ESMO Precision Medicine Glossary in Annals of Oncology. The glossary’s 43 definitions are set to pave the way for consistent communication on precision medicine between oncologists, ...
Leggi tutto

17 Novembre 2017

Clinical Outcomes in Patients With Metastatic Lung Cancer Treated With PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy

Immune checkpoint inhibitors (CPIs) have become integral in the treatment of patients with advanced lung cancer but are associated with immune-related adverse events (IRAEs). Many of these patients also receive thoracic radiotherapy (TRT). A better understanding of potential ...
Leggi tutto

17 Novembre 2017

13 novembre 2017 – Comitato per i Medicinali per Uso umano (CHMP) dell’EMA: highlights del meeting di novembre

17 Novembre 2017

13 novembre 2017 – AIFA: secondo incontro con gli operatori della farmacovigilanza sulle novità della RNF e di EudraVigilance

17 Novembre 2017

16 novembre 2017 – Rettifica: Carenza Vaccino del Papillomavirus umano (tipi 6, 11, 16, 18, 31, 33, 45, 52, 58) (Ricombinante, adsorbito) – modalità di richiesta d’importazione dall’estero